Hui Ding
Impact in
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Angiogenesis and VEGF in Cancer 4
- Genomics, phytochemicals, and oxidative stress 3
- Circular RNAs in diseases 2
- Wnt/β-catenin signaling in development and cancer 2
- Epigenetics and DNA Methylation 2
-
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Xiaoxu Zhao (7 shared papers)Yue Jia (4 shared papers)Hao Pan (3 shared papers)Yunlong Pan (5 shared papers)Handong Wang (3 shared papers)Qin Li (4 shared papers)Fan Pan (3 shared papers)Xinxin Ci (1 shared paper)
- Journals
- Oncology Reports (3 papers)Sleep And Breathing (2 papers)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (1 paper)Biochemical and Biophysical Research Communications (1 paper)International Immunopharmacology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Hui Ding
26 papers receiving 521 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 90
- Geriatrics and Gerontology 16
- Biomaterials 66
- Molecular Biology 268
- Immunology 61
Countries citing papers authored by Hui Ding
This map shows the geographic impact of Hui Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Ding more than expected).
Fields of papers citing papers by Hui Ding
This network shows the impact of papers produced by Hui Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Ding. The network helps show where Hui Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 98 | |
| 2 | 2018 | 62 | |
| 3 | 2017 | 55 | |
| 4 | 2015 | 32 | |
| 5 | 2017 | 29 | |
| 6 | 2017 | 29 | |
| 7 | 2018 | 26 | |
| 8 | 2018 | 25 | |
| 9 | 2013 | 24 | |
| 10 | 2010 | 23 | |
| 11 | 2018 | 22 | |
| 12 | 2014 | 15 | |
| 13 | 2023 | 13 | |
| 14 | 2018 | 12 | |
| 15 | 2017 | 11 | |
| 16 | 2022 | 10 | |
| 17 | 2023 | 7 | |
| 18 | 2021 | 7 | |
| 19 | 2024 | 6 | |
| 20 | 2022 | 5 |
About Hui Ding
Hui Ding is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Biomaterials, having authored 26 papers that have together received 523 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Cancer Cells and Metastasis (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Circular RNAs in diseases (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (90 citations), Geriatrics and Gerontology (16 citations), Biomaterials (66 citations), Molecular Biology (268 citations) and Immunology (61 citations). Hui Ding has collaborated with scholars based in China and United States. Frequent co-authors include Xiaoxu Zhao, Yue Jia, Hao Pan, Yunlong Pan, Handong Wang, Qin Li, Fan Pan, Xinxin Ci, Shuhao Liu and Wende Yang. Their work appears in journals such as Oncology Reports, Sleep And Breathing, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Biochemical and Biophysical Research Communications and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.